At American Gene Technologies we are very proud and fortunate to work with some of the best scientific and clinical advisors in their fields. As a team we continually push our research forward.
LEADERSHIP TEAM
MANAGEMENT TEAM
Our experienced executive team is committed to finding innovative solutions for patients living with infectious diseases, cancer, and monogenic disorders.
Jeff Galvin
CEO and
Founder
Jeff earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies.
C. David Pauza, PhD
Chief Science
Officer
David has 35 years of experience in human viral diseases, immunology and cancer biology with more than 200 publications. Prior to joining AGT he held faculty positions at the University of Wisconsin School of Medicine and University of Maryland Medical School where he is now Adjunct Professor of Medicine.
Andrew Miller, CPA
VP of Finance
Andrew has more than 20 years of experience in accounting, finance, strategy, raising capital, and corporate governance in both private companies and non-profit organizations.
BOARD OF DIRECTORS
Jeff Galvin
CEO and Founder
Jeff earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of…
Jason T. Thompson
Director
Jason combines legal experience and strategic vision in helping his clients structure, negotiate, and integrate corporate acquisitions. His training as a certified public accountant adds...
Aaron Galvin
Director
Aaron Galvin earned his BS and MS from the Massachusetts Institute of Technology (MIT), joining the MIT Lincoln Labs to pioneer innovations to radar as well as developing technologies for various classified…
Qi Tang
Director
Qi Tang has developed manufacturing and import/export businesses throughout China and the United States, and has invested several times throughout AGT’s growth.
Julia Brown
Director
Julia Brown has served on the board of directors of nine drug development companies with a focus on governance and compensation. She currently serves on the board and as a member of the…
PROFESSIONAL ADVISORS
Tommy Thompson
Senior Advisor to the CEO
Tommy Thompson, former Secretary of the United States Department of Health and Human Services, worked fervently to modernize healthcare delivery as the former Governor of…
Dr. Robert R. Redfield
Special Advisor to the CEO
Dr. Redfield is well known for his decades of dedicated work in virology, immunology and clinical research. He has helped lead collaborative research into HIV/AIDS since the beginning of the epidemic...
Snell & Wilmer strategically develops our intellectual property.
Foley & Lardner protects our innovative technologies and cures.
Cooley, LLP provides AGT with corporate legal advice.
Ernst & Young serves as our independent public accountant.
